Antonio Giordano/cst.temple.edu
Jun 15, 2025, 10:20
Antonio Giordano: Our Latest Work Lays the Foundation for Biomarker Development in MPM
Antonio Giordano, President of the Sbarro Health Research Organization, shared a post on LinkedIn:
“Our latest work, published in Experimental and Molecular Pathology, lays the foundation for future investigations, including the development of biomarkers, with potential implications for the diagnostic and prognostic assessment of MPM.”
More posts featuring Antonio Giordano.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 5, 2025, 20:31
Jul 5, 2025, 20:15
Jul 5, 2025, 20:00
Jul 5, 2025, 19:18
Jul 5, 2025, 18:52
Jul 5, 2025, 18:38